Ken Griffin Opko Health, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.21 - $1.68 $107,206 - $148,848	88,600 Added 15.16%	673,000 $1 Million
Q2 2024 Aug 14, 2024	BUY	$1.21 - $1.42 $107,448 - $126,096	88,800 Added 17.92%	584,400 $730,000
Q1 2024 May 15, 2024	BUY	$0.87 - $1.57 $250,734 - $452,474	288,200 Added 138.96%	495,600 $594,000
Q4 2023 Feb 14, 2024	BUY	$1.23 - $1.63 $6,888 - $9,128	5,600 Added 2.78%	207,400 $313,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.17 $9,600 - $13,888	6,400 Added 3.28%	201,800 $322,000
Q2 2023 Aug 14, 2023	BUY	$1.37 - $2.17 $72,473 - $114,793	52,900 Added 37.12%	195,400 $424,000
Q1 2023 May 15, 2023	SELL	$1.06 - $1.61 $23,002 - $34,937	-21,700 Reduced 13.22%	142,500 $208,000
Q4 2022 Feb 14, 2023	SELL	$1.05 - $2.01 $1,785 - $3,416	-1,700 Reduced 1.02%	164,200 $205,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.81 $5,792 - $8,992	-3,200 Reduced 1.89%	165,900 $314,000

256

187M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.24B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.